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ABSTRACT
The final step in the maturation of paramyxoviruses,
orthomyxoviruses and viruses of several other
families, entails the budding of the viral nucleo-
capsid through the plasma membrane of the host
cell. Many medically important viruses, such as
influenza, parainfluenza, respiratory syncytial virus
(RSV) and Ebola, can form filamentous particles
when budding. Although filamentous virions
have been previously studied, details of how viral
filaments bud from the plasma membrane remain
largely unknown. Using molecular beacon
(MB)-fluorescent probes to image the viral genomic
RNA (vRNA) of human RSV (hRSV) in live Vero cells,
the dynamics of assembled viral filaments was
observed to consist of three primary types of
motion prior to egress from the plasma membrane:
(i) filament projection and rotation, (ii) migration
and (iii) non-directed motion. In addition, from
information gained by imaging the 3D distribution
of cellular vRNA, observing and characterizing
vRNA dynamics, imaging vRNA/Myosin Va coloca-
lization, and studying the effects of cytochalasin D
(actin depolymerizing agent) exposure, a model
for filamentous virion egress is presented.
INTRODUCTION
Several medically important enveloped viruses that infect
the respiratory tract, such as inﬂuenza (1–3), respiratory
syncytial virus (RSV) (4–8), and parainﬂuenza (9) virus,
form both spherical and ﬁlamentous virions at the surface
of infected cells. This has been observed both in cell
culture models with high passage, laboratory strains,
and from virus isolated directly from nasopharyngeal
secretions or observed in pathology samples (7). It has
been shown that in inﬂuenza, ﬁlamentous virions have a
higher speciﬁc infectivity (2), and it has been theorized
that the ﬁlamentous virus morphology may be more
eﬀective for both infecting cells and evading the host
immune responses, particularly in the respiratory tract (3).
One important question about the ﬁlamentous virion is:
What are the mechanisms by which these virions bud from
the plasma membrane of an infected cell? To answer this
question, we chose as our model system the A2 strain
of human respiratory syncytial virus (hRSV), grown in
non-polarized Vero cells. Since many aspects of virion
assembly and replication have been studied with RSV,
this system is ideal for the study of ﬁlamentous virion
egress. To image the live-cell dynamics of the genomic
viral ribonucleoprotein (vRNP) of hRSV, a molecular
beacon (MB)-ﬂuorescent probe was designed to target
speciﬁcally the vRNA. This allowed for direct observa-
tions of both the morphology and mechanics of the
processes leading to viral egress within the cellular
context. This approach has signiﬁcant advantages over
the DIC (diﬀerential interference contrast) method used
in the previous dynamics study (10) of RSV, which lacked
molecular speciﬁcity and the contrast needed to observe
vertically oriented virions.
Molecular beacons are dual-labeled, nucleic acid probes
with a reporter ﬂuorophore at one end and a quencher
at the other. They are designed to form a stem-loop
hairpin structure so that ﬂuorescence emission occurs only
when the probe hybridizes to a complementary target,
resulting in a high signal-to-background ratio (SBR) (11).
Although MBs have been used in limited live-cell mRNA
studies (12–16), their potential for the analysis of viral
RNA in living cells has only recently been demonstrated
(17,18). Other methods for imaging RNA in live cells,
including the use of ﬂuorescently labeled full-length RNAs
or RNPs (19–22) and GFP-fused RNA-binding proteins
(GFP-MS2) (23), do not allow for the evaluation of
unmodiﬁed viral particles.
For the imaging experiments, a single chimeric MB,
with a DNA backbone stem and 20-O-Methyl RNA
backbone hybridization domain, was designed to target
a gene-end-intergenic-gene-start sequence, 30-UUU UUA
CCC CGU UUA U-50, that has three exact repeats
(Figure 1A) (24,25). Successfully used in antisense
experiments (24,25), this site was considered the most
accessible and therefore a prime site for probe hybridiza-
tion. Targeting the repeated sequence provided signal
ampliﬁcation, resulting in a signiﬁcantly increased SBR.
In addition, since the target RNP is concentrated in
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viral ﬁlaments, which contain multiple copies of the
vRNP, the signal was further enhanced. A 20-O-Methyl
RNA/DNA chimera design was used for the MB
primarily because of its generally higher SBR (26) when
binding to RNA. This enhanced our ability to observe
viral RNA being packaged into ﬁlamentous virion
(SBR ranging from 11 to 30 using chimera versus less
than 5 using DNA), and is likely due to 20-O-Methyl
RNAs higher aﬃnity for RNA than DNA (27–29).
The enhanced nuclease resistance is also a positive
feature of using 20-O-Methyl RNA for the hybridization
domain (28), but we did not ever observe evidence of
active probe degradation with DNA or chimera probes.
The lack of probe degradation is likely due to the use of




Vero cells (ATCC CCL-81) were grown in DMEM (Sigma
Aldrich, St. Louis, MO) with 10% FBS (ATCC) with
100U/ml of penicillin and 100mg/ml of streptomycin.
Virus used was the A2 strain of RSV (ATCC VR-1544)
at a titer of 1 10
6 TCID50/ml. The titer was evaluated by
serial dilution and immunostaining, 4-days post-infection
(PI). All data shown was at day 2 PI and with a
multiplicity of infection (MOI) of 0.5. At 48h numerous
synctia had formed, but no cell death had occurred.
All cells were infected at 80–90% conﬂuence, by removing
the media, followed by washing with 1  PBS (without
Ca
þ and Mg
þ2), and then adding virus to the cells for
30min at 378C. After the 30-min incubation, regular
media were added.
Figure 1. Characterization of the vRNPs of hRSV in live cells using molecular beacon imaging. (A) A schematic showing the genomic organization
of hRSV with black ellipses indicating the sequence locations where the molecular beacon probe was targeted. (B) Image of non-infected (NI) and
2-day post-infection (IN) Vero cells, 30min after MBs targeting the genomic vRNA of hRSV were delivered into them; infected cells exhibit highly
localized signal in both inclusion bodies (aggregates of vRNA) and groups of ﬁlamentous vRNPs. (C) PCR results from non-infected (NI)
and infected (IN) cells 2-day post-infection; no product was formed for the NI case, while the IN case showed a strong PCR product at 940bp.
(D) Results from live-cell delivery and hybridization of Quasar570-labeled MB to vRNA in infected cells, together with ﬁxation and antibody
staining (Alexa488) for hRSV F protein, indicating that molecular beacons could hybridize to vRNPs when they are being packaged for egress.
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The MB used in this study was a DNA/20-O-Methyl RNA
chimera, 50-Quasar570-ctcgacg AAAAAUGGGGCAA
AUA cgtcgag–BHQ2 -30 (Biosearch Technologies,
Novato, CA) where the underlined sequences represent
the MB stem, lower case are DNA, and the upper case are
20-O-Methyl RNA. The beacon’s SBR ratio in solution
(beacon to target ratio was 1:2 in 1  PBS buﬀer)
was measured to be  50 using a Tecan Saﬁre ﬂuorescent
platereader.
Live-cell molecular beacondelivery
Molecular beacons were delivered into infected and
uninfected live, Vero cells on day 2 PI using a reversible
permeabilization method with streptolysin O (SLO)
(Sigma). Cells grown in normal medium were ﬁrst
washed with serum-free medium and then incubated
with a mixture of 0.2U/ml of SLO and 1mMo fM B
in an appropriate amount of serum-free medium for
10min at 378C. The SLO/MB/serum-free medium was
then removed and replaced with fresh, normal medium.
For live-cell imaging, the cells were imaged via epiﬂuor-
escence microscopy, 20min after incubation in normal
growth medium. Using SLO-based delivery, MBs were
delivered into Vero cells with  100% eﬃciency.
PCR primers andconditions
Total RNA was isolated from infected and non-infected
Vero cells, day 2 PI using the Qiagen RNeasy Mini Plus
kit, as per the manufacturers instructions. Reverse
transcription was performed using the Thermoscript
reverse transcriptase with typical conditions. Primers
called BC6: 50-TAA TTT TCA GGC TCC ATC TG-30,
and OD1: 50-TGT TTG ACA ATG ATG AAG TA–30
were used to amplify the gene end-intergenic-gene start
region between the viral genes NS1 and NS2 (25).
The cycle conditions were as follows: stage 1: 958C 5min
1 ; stage 2: 958C3 0 s ;5 8 8C for 45s; 728C 90s stage 3:
728C 10min 1 , using the Invitrogen Thermoscript
RT-PCR system with Platinum Taq DNA Polymerase.
Simultaneous labeling
In order to verify MB hybridization to vRNA during
virion assembly, Vero cells, 2-day PI, were simultaneously
labeled with both MBs for the vRNA of hRSV and
with a monoclonal antibody (mAb) (Abcam RSV3206)
for the hRSV F protein. Infected cells were live-cell
labeled with the hRSV speciﬁc MB as discussed above.
Thirty minutes after live-cell MB hybridization, cells were
ﬁxed with room temperature (RT) 4% paraformaldehyde
(Electron Microscopy Sciences, Hatﬁeld, PA) in nuclease
free PBS for 10min. They were then washed twice with
1  PBS and incubated in 5% RNase-free BSA (Fisher
Scientiﬁc, Horsham, PA) in 1  PBS for 60min at RT.
They were then washed twice with 1  PBS and incubated
with a 1:500 dilution of mAb RSV3206 (Abcam,
Cambridge, MA) for 60min at RT. After being washed
twice with 1  PBS for 5min, the cells were then incubated
with a 1:400 dilution of Alexa 488-goat-anti-mouse IgG
secondary antibody (Invitrogen, Carlsbad, CA). Cells
were then washed twice with 1  PBS, mounted in Zymed
clearmount and imaged.
This procedure was repeated when labeling vRNA and
lipid rafts, except 30min after live-cell MB hybridization,
the Vybrant Lipid Raft Labeling Kit from Invitrogen was
used as per the manufacturers’ instructions on the live
cells, ﬁxed with 4% paraformaldehyde, and then imaged.
For staining vRNA and myosin Va, the vRNA was
labeled in live-cells with the MB as mentioned above,
ﬁxed as mentioned above, but in addition were perme-
abilized 0.1% Triton X in 1  PBS for 3min, followed by
a1   PBS wash after ﬁxation. The primary antibody used
was a rabbit polyclonal to myosin Va (Santa Cruz
Biotech, Santa Cruz, CA) at a 1:100 dilution in PBS;
the secondary antibody used was an Alexa 488-goat-anti-
rabbit IgG (Invitrogen).
Cytochalasin D treatment
In order to further understand the role of actin in the
dynamics of viral genomic RNPs, MBs were delivered into
Vero cells 2-day PI. Thirty minutes after MB delivery the
cell media were removed and replaced with their normal
growth media with 3mg/ml of cytochalasin-D bodipy FL
(Invitrogen). Time-lapse epiﬂuorescence imaging of the
cells was performed at 378C and 5% CO2, immediately
after the media were changed for  15min. Out of focus
light was removed using ImageJ ‘background subtraction’
in order to improve the contrast of the ﬁlaments shown.
No other alterations were performed.
3D reconstructions
Fixed cell images (in 4% paraformaldehyde in 1  PBS)
of vRNPs or vRNP/myosin Va co-stained samples were
imaged using a Zeiss LSM 510 Meta confocal micro-
scope with a 100X Plan-Neoﬂuor objective (NA¼1.3).
The pinhole for the confocal microscopy was set such that
each image is 0.5mm thick, with 0.5mm between images,
and up to 31 images ( 15mm in the z direction) were
taken. Bitplane was utilized to reconstruct the z-stack
images. This enabled the actual length of the vRNPs to be
measured, not just the 2D projection length.
Live-cell imaging
All of the live-cell imaging performed was with a Zeiss
Axiovert 200 epiﬂuorescence microscope equipped with
an internal shutter, and a Zeiss Axiocam MRm cooled
CCD camera. Control of the internal shutter and image
acquisition was performed using Zeiss Axiovision 4.4.
Chroma ﬁlter sets 41007a and 49002 were used to image
the Quasar570 and Alexa 488 ﬂuorescence, respectively.
All images were taken with a 100X EC-Plan-Neoﬂuor
objective (NA¼1.3). Fixed cell imaging was performed in
4-well, Nunc Labtek II chambered coverslips (#1.5),
while all live-cell imaging was performed with Bioptechs
DeltaT black dishes with a #1.5 coverslip for a bottom.
The live cells were kept at 378C using the Bioptechs
DeltaT4 system and objective heater, and in a 5% CO2 in
air environments via a port in the heated lid of the
DeltaT4 system.
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1.33u, or using Bitplane by Imaris. ImageJ was utilized to
produce the image sequence data from the time-lapse
images of vRNP dynamics, and to false color the images.
The only modiﬁcation to the time-lapse images was the
mapping of the 8-bit gray scale to the ‘ﬁre’ color maps in
ImageJ. No other changes to the images were performed.
SBR measurements were performed with the background
intensities of both the non-infected and infected cells being
the same value. Only linear changes were made to
equilibrate their backgrounds. In addition, ImageJ and
Bitplane were used to analyze the motion of vRNPs and
the length of ﬁlamentous vRNPs. This information was
then used in Microsoft Excel to calculate the mean square
displacement (MSD) of the vRNPs as a function of time,
and the ﬁlament length distribution.
RESULTS
Molecular beacons were delivered into a conﬂuent
monolayer of Vero cells 2-day PI with the A2 strain of
hRSV, as well as non-infected Vero cells, using reversible
cell membrane permeabilization with streptolysin O (12),
in order to determine both the speciﬁcity of the MB probe
(17) and characterize the morphologies of the vRNPs.
As seen in Figure 1B, infected cells exhibited strong
ﬂuorescence with signal concentrated in spherical inclu-
sion bodies (average SBR of 80) and individual viral
ﬁlaments (average SBR of 11), while the non-infected cells
were quite dark, demonstrating excellent probe speciﬁcity.
The infection was conﬁrmed using PCR; infected cells
exhibited a very high level of hRSV amplicon, unlike the
non-infected cells (Figure 1C). To demonstrate probe
accessibility for vRNPs that were in the process of being
packaged, we ﬁxed the hRSV-infected cells after delivering
MBs, and then co-stained for the RSV F protein with
indirect immunoﬂuorescence. The F or fusion protein is
a membrane glycoprotein that mediates viral fusion
and entry, and also promotes fusion of the infected cell
membrane with adjacent cell membranes, leading to the
formation of syncytia. We observed signiﬁcant image
overlap of the ﬁlamentous MB signal with that from
the anti-F-protein antibody on the surface of the cells,
indicating that MBs can bind to vRNPs localized to
the inside of the plasma membrane in the midst of the
packaging process (Figure 1D). In addition, the F protein
and MB signal colocalization implies that the RNPs are
located throughout the ﬁlament.
In order to better describe the morphologies observed
using MB imaging in the infected cells, 30min after MB
delivery, the cells were ﬁxed, imaged with confocal
microscopy and later reconstructed in three dimensions
using Imaris Bitplane. In Figure 2A, four images showing
only the ﬂuorescent information at distances greater than
12, 8, 4 and 0mm from the glass surface are shown.
The 0mm view represents all of the signal from the bound
MBs within the infected cells displayed in two dimensions;
the cross section is  15mm thick from the coverglass to
the tops of the viral ﬁlaments (as represented by the
ﬂuorescent signal). Both cytoplasmic inclusions and viral
ﬁlaments are easily viewed and measured, with the upper
3mm (perpendicular to the image plane) dominated by
ﬁlaments. In Figure 2B, one XZ and YZ cross section are
shown. In these cross-sectional views, the ﬁlaments are
easily seen protruding from the curved, apical side of the
cells, while the inclusions are distributed throughout
the cytoplasm, but often closer to the apical membrane
Figure 2. Two-dimensional representations of viral RNPs imaged via
MB hybridization. (A) Four images showing only the ﬂuorescent
information at distances greater than 12, 8, 4 and 0mm, from the glass
surface. The cross section is  15mm thick from the coverglass to the
tops of the ﬁlaments. Both cytoplasmic inclusions and viral ﬁlaments
are easily viewed and measured, with the upper 3mm (perpendicular to
the image plane) dominated by ﬁlaments. (B) XZ and YZ cross sections
are shown; the ﬁlaments are easily seen protruding from the curved,
apical side of the cells, while the inclusions are distributed throughout
the cytoplasm, but often closer to the apical membrane than the
coverslip. Two examples of connected ﬁlaments are indicated by the
white circles. (C) Plot of ﬁlament length distribution.
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reconstructions were measured in Bitplane, and the
distribution is plotted in Figure 2C. The distribution is
log-normal, ranging from  2.6 to 8.1mm, with an average
ﬁlament length of 4.6mm and a SD of 1.54mm. This is very
consistent with prior measurements of ﬁlament length
measured using electron microscopy; Armstrong et al. (4)
quoted lengths up to 2.5mm, Norrby et al. (8) greater than
2mm, Bachi and Howe (5) up to 10mm, Berthiaume et al.
(6) up to 5mm, and measurements by Roberts et al. (7)
quoted a range from 4 to 8mm. In addition, we found that
some ﬁlamentous vRNPs (Figure 2B, white circles) are
connected at one end, with average angles of  71.4 3.58,
which is very similar to morphologies formed by the actin
network near the plasma membrane (30,31).
Time-lapse imaging experiments were performed on
Vero cells, 2-day PI, in order to observe the dynamics
leading to virion egress. Images of infected cells were
taken using 100–200ms exposures, with 5s between
exposures for up to 15min, after which photobleaching
became signiﬁcant. Twelve image sequences were taken
per experiment and 10 experiments were performed,
yielding 120 time-lapse movies. After analyzing the
movie sequences, three primary modes of motion were
identiﬁed: (i) ﬁlament projection and rotation, (ii) migra-
tion, and (iii) non-directed motion. As shown in Figure 3A
and Supplementary Movie 1, ﬁlamentous vRNPs on the
surface of the cells rotated dramatically on one end after a
period of little motion. A quantitative analysis indicated
that the vRNPs in Figure 3A exhibited little rotation for
 250s, then rapidly rotated to a near vertical position
relative to the cell membrane within 50s (Figure 3B).
The average rate of rotation after the vRNPs appeared to
separate from the membrane was  1.678/s. Once the
vRNPs became vertical, they either continued to rotate
rapidly (Figure 3C and Supplementary Movie 2), with
a rate  68/s, or they migrated over short distances,
exhibiting the second mode of motion observed (migra-
tion). It should be noted that the ﬁlamentous groups of
vRNPs observed while rotating are ﬂexible in nature.
An example of a ﬂexible ﬁlament can be observed in
Figure 3D, panel two (5s, where the ﬁlament appears
‘bent’), and panel three (10s, where the ﬁlament appears
curved) and in Supplementary Movie 2. The ﬂexibility
of RSV nucleocapsids has previously been noted (32), but
were not observed in real-time during the egress process.
A typical example of the migration mode can be seen in
Figure 4A and Supplementary Movie 3, where a vertically
oriented vRNP migrated  2.8mm in 50s; the path of the
vRNP is plotted in Figure 4B. Prior to and after this
migration, the particle is static. The path taken by
the particle is very similar in morphology to that of
lipid rafts (see inset in Figure 4B) as imaged using an
Alexa 488-labeled cholera toxin probe. We hypothesize
that the raft acts as a guide for the particle path, which is
consistent with the observation that vRNP packaging
occurs in the lipid rafts (33–36). The speeds observed of
 25 migrating ﬁlaments ranged from  29.5 to 102 nm/s
with an average speed of 56nm/s, while the path lengths
traveled ranged from  1t o4 mm, with an average
path length of 2.36 0.9mm. The speeds measured are
commensurate with myosin transport (37); myosin has
been implicated in RSV viral protein traﬃcking (38) and
given the connection between lipid rafts and the actin
network (39), myosin-driven transport likely plays a role
in RSV virion egress.
In addition, many vRNPs exhibited non-directed
motion over periods greater than 15min, as illustrated in
Figure 4C and Supplementary Movie 4 (A control video,
where MBs were delivered into non-infected Vero cells,
can be seen in Supplementary Movie 5). In order to
compare the motion seen in Figure 4A with that observed
in 4C, and gain insight into the nature of the motion,
the MSD or r2 
of each trajectory was calculated
(Figure 4D). It was determined that for the motion in
Figure 4A, the MSD (Figure 4D), could be ﬁt by a




v¼29.05 nm/s, with an R
2¼0.984, representing directed
motion; while the motion in Figure 4C could be ﬁt
(R
2¼0.7) by a power law function r2 
¼4Dt
a, where
4D¼0.013 and a¼0.78 (R
2¼0.7), which is between
0.55a50.9 representing anomalous diﬀusion or
obstructed diﬀusion (22,40,41). The calculations shown
in Figure 4D are for the particles shown, but are
representative of the populations exhibiting these
modes of motion. In Figure 4E, the fraction of ﬁlaments
exhibiting each mode of motion is presented.
Approximately 36% exhibit projection and rotation,
12% migration and 52% non-directed motion.
DISCUSSION
Role of actinand myosin
In the previous section, evidence of the directed motion of
the RSV ﬁlamentous vRNPs was presented. This evidence,
in conjunction with previous studies of RSV ﬁlaments
(34–36,42–46), points to motor driven transport on the
cytoskeleton as the likely driver of the observed migratory
motion, and possibly the rotational motion. Previous
studies of RSV have demonstrated that actin ﬁlaments
(42,46) and their growth, mediated by proﬁlin (43) and
rhoA activation (44), are vital to virion egress. In many
of those studies, infected cells were exposed to cytoskeletal
depolymerizing agents. The amount of free virion or
viral RNA in the cell culture media, or changes in virion
morphology, as measured via immunoﬂuorescence
imaging, were used to gauge the eﬀect of these agents on
virion egress. In previous studies, actin depolymerization
via cytochalasin D had the most adverse eﬀects on virion
egress, therefore making actin/myosin the most likely
cytoskeletal/motor combination involved in the motion
observed in our investigation. In addition, since assembly
occurs at the lipid rafts and the rafts are linked to the actin
network (39), depolymerzing them should eﬀect the
observed motion.
Live-cell MB hybridization, cell ﬁxation and permeabil-
ization, followed by immunostaining of myosin Va, and
confocal microscopy imaging was performed in order
to conﬁrm the presence and possible role of myosin.
Myosin V has previously been implicated in traﬃcking
messenger RNP (47), granules on the actin network near
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membrane in polarized cells (38). The results from our
simultaneous labeling experiments can be seen in Figure 5,
where the blue represents myosin Va, the red represents
vRNPs (hybridized MBs) and the purple represents their
colocalization. In Figure 5A, like Figure 2A, four images
showing only the ﬂuorescence information at distances
greater than 9, 6, 3 and 0mm from the glass surface are
shown. The 0mm view represents all of the ﬂuorescent
signal from within the infected cells, displayed in two
dimensions; the cross section is  12mm thick from the
coverglass to the tops of the viral ﬁlaments. In Figure 5B,
XZ and YZ cross-sectional views are shown, with crossed
lines representing where they were taken in the XY plane.
Figure 3. Time-lapse ﬂuorescent imaging of the rotational dynamics of hRSV ﬁlamentous vRNPs. (A) Time series of the dynamics of vRNPs
(white box), exhibiting the projection and rotation mode of motion. (B) Quantiﬁcation of rotation angle; after 250s of very limited motion, the virion
rapidly rotates to near vertical (represented by the vertical black line), possibly separating much of it from the plasma membrane. The angle
measurement was made relative to the vRNPs initial position at the cell membrane. The initial position was conﬁrmed via ﬂuorescence imaging to be
at the cell membrane, via the vRNPs colocalization with the lipid rafts (data not shown). (C) Once the vRNPs are vertical, two types of motion were
observed, violent rotation (see Supplementary Movie 2) or migration. A time series of the rapid rotation of packaged vRNPs is shown here; where
within 15s, the vRNPs pictured here rotate 69.48.( D) The ﬂexibility of RSV ﬁlaments is shown in this time-lapse sequence. The RSV ﬁlament
appears both ‘bent’ and exhibits curvature at both 5 and 10s from the initial time of observation.
Nucleic Acids Research, 2007, Vol. 35, No. 11 3607From the data in Figure 5A and B, it can be seen that
the ﬁlaments are largely distributed along the apical
surface, and that they colocalize well with myosin Va
(purple color). Throughout the volume of the cell
monolayer, both myosin Va (blue), represented as small
dots, and vRNPs (MB, red), predominately in cytoplasmic
inclusions, do not colocalize and appear independent.
It is clear from this ﬁgure that the strongest colocalization
occurs predominately in the ﬁlaments and near the surface
of the monolayer, implicating myosin Va’s role in the
assembly and egress process.
Vero cells 2-day PI and hybridized with RSV targeted
MBs, were exposed to cytochalasin D, an actin depoly-
merising agent, in order to provide further evidence for the
role of actin on the vRNP morphology and dynamics.
We observed that many ﬁlamentous vRNPs exposed to
cytochalasin D, tended to aggregate and form circular,
inclusion-like structures of vRNPs within  1min
(Figure 6A and Supplementary Movie 6). Two minutes
later, these circular aggregates tended to move from the
surface of the cell into the cell cytoplasm. After 15min,
almost all of the vRNPs had separated from the cell
surface and were concentrated in granules. In Figure 6B,
a typical syncytia is shown; high concentrations of
ﬁlamentous structures surround the syncytia, while a
lower density of ﬁlaments and particles lie along the apical
membrane. However, as shown in Figure 6C, a syncytia
15min after cytochalasin D exposure composed of
predominately circular granules. This experiment helps
conﬁrm ﬁlamentous actin’s role in governing vRNP
morphology, and explain why virion egress is decreased
when actin ﬁlaments are depolymerized.
From the data presented in this investigation and from
previous studies, we hypothesize that actin ﬁlaments and
myosin-driven motion are the root cause of the motion
observed, and such motion is mechanically separating the
packaged vRNPs from the actin network, thus allowing
them to leave the cell.
Biophysical model of virionegress
In order to further explain the observed dynamics of
ﬁlamentous vRNPs in live cells, we propose a biophysical
model. Presented in Figure 7A–D are sketches of the
possible actin network/nucleocapsid interactions for all
three types of motion discussed above. Figure 7A and B
represents how vRNP rotation might be achieved. Myosin
motors, attached to the vRNP and moving along the actin
network, could cause the virion to ﬂip up on one end
(Figure 3A), given that actin ﬁlaments are quite ﬂexible.
It is possible that this motion frees much of the
virion from the plasma membrane, allowing for more
rigorous rotation (Figure 3C) or migration (Figure 4A).
The rigorous rotation may cause the separation of
daughter actin strands within the virion from mother
strands at the Arp2/3 interface (31,49). The dissociation
Figure 4. Migration and diﬀusion dynamics of hRSV ﬁlamentous vRNPs. (A) A time series of the dynamics of vRNPs (white box), exhibiting
migration. (B) The trajectory of migration (from the point labeled 1 and ending with the point labeled 10) is shown in (B). The shape of the
trajectory shown in (B), is very similar to the shape of the lipid rafts of Vero cells, as can be seen in the inset image, with a typical raft ( 1.2mmi n
length) circled in red. (C) A time series of vRNPs exhibiting non-directed motion or anomalous diﬀusion is shown. (D) Plot of the mean square
displacement (MSD) or r2 
of trajectories presented in (A) and (C). The MSD of (A) was ﬁt with a parabola, representing directed motion; while for
the motion in (C) could be ﬁt by a power law ﬁt with an exponential value between 0.5 and 0.9 representing anomalous diﬀusion or obstructed
diﬀusion. (E) Plot of the relative fraction of ﬁlaments exhibiting each of the three types of motion observed.
3608 Nucleic Acids Research, 2007, Vol. 35, No. 11constant for Arp2/3 with the mother strand is  50 times
higher than with the daughter strand, and thus the
weakest part of the structure (37). This separation would
then allow the virion to leave the cell. The initiation of
migration (Figure 4A) may be the result of myosin motors
as a part of the virion, and their intermittent function
once the vRNPs are physically separated from the actin
network. This is supported by our observation of myosin
Va colocalization with vRNPs (see Figure 5A and B).
Non-directed motion or anomalous diﬀusion (Figure 4C)
may occur for several reasons; for example, if vRNPs
lack the ATP necessary to cause directed motion or if
the vRNPs are separated from the actin network via the
ADF/coﬁlin mechanism (31) too early and not by
mechanical motion, they may be left trapped within the
Figure 5. Simultaneous imaging of vRNPs and Myosin Va. (A) Four
images showing only the ﬂuorescence information at distances greater
than 9, 6, 3 and 0mm from the glass surface are shown. The cross
section is 12mm thick from the coverglass to the tops of the ﬁlaments.
Myosin Va is represented in blue, vRNPs in red and the colocalization
in purple. (B) XZ and YZ cross-sectional views. The ﬁlaments are
largely distributed along the apical surface, and colocalize with myosin
Va. Throughout the volume of the cell monolayer, myosin Va, small
dots and vRNPs, predominately in cytoplasmic inclusions, do not
colocalize and appear independent.
Figure 6. Actin’s role in vRNP dynamics and morphology. (A) Seven
images representing the time-lapse eﬀects of cytochalasin D on the
morphology and location of ﬁlamentous vRNPs. Initially ﬁlamentous
vRNPs tended to aggregate and form circular aggregates within 1min
of exposure to media containing cytochalasin D. By 3min, these
circular aggregates, tended to move from the surface of the cell into the
cell cytoplasm. (B) Representative example of a typical syncytia,
showing high concentrations of ﬁlamentous structures around the
outside of the syncytia and a lower concentration along the apical
surface. (C) Representative image of a syncytia after cytochalasin D
exposure, composed of predominately circular granules.
Figure 7. Hypothesized biophysical model of vRNP motion. (A) Active
myosin V motor proteins, attached to both the viral genomic RNP and
the actin network, cause the rotation of the virion and partial
separation from the plasma membrane, via their translation along the
actin network. (B and C) Once the virion is partially free from the cell
surface due to vigorous motion (B), motor motion could possibly cause
daughter actin ﬁlaments within the virion to break from the mother
ﬁlaments at the Arp2/3 protein complex, allowing for rigorous rotation
(Figure 3C and Supplementary Movie 2) or (C) migration along the
actin network (Figure 4A and Supplementary Movie 3). (D) Some
particles exhibit ‘non-directed’ or obstructed diﬀusion (Figure 3C and
Supplementary Movie 4), possibly due to the action of the ADF/coﬁlin
complex leaving it embedded in the membrane without the actin
network/motors to propel it from the cell.
Nucleic Acids Research, 2007, Vol. 35, No. 11 3609plasma membrane. It is also possible that these virions
were released from an infected cell earlier and reabsorbed,
or they are involved in genome replication, and not
competent for egress. Future studies of the protein/vRNP
interactions at the membrane are required to reveal the
exact reasons of the non-directed motions, and identify
conclusively the proteins involved in this process.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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